EMA short­ens time­line for Mod­er­na's Spike­vax Covid boost­er 

Just two days af­ter Mod­er­na signed a 15-year al­liance with Ther­mo Fish­er, the Mass­a­chu­setts biotech notched a short­ened time­line for its Covid-19 vac­cine boost­er fol­low­ing the pri­ma­ry se­ries in the EU.

EMA’s hu­man med­i­cines com­mit­tee (CHMP) yes­ter­day rec­om­mend­ed re­duc­ing the in­ter­val be­tween pri­ma­ry and boost­er dose vac­ci­na­tion with Mod­er­na’s Covid-19 vac­cine Spike­vax from six to three months.

The move fol­lows coun­tries that had al­ready short­ened the in­ter­val on their own be­tween the orig­i­nal two-dose reg­i­men and the boost­er, in­clud­ing Greece and France.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER